Form 4 Filing for Beta Bionics, Inc. - Insider Transaction

This filing details a Form 4 submission for Beta Bionics, Inc. (BBNX), reporting an insider transaction by CARNEY SEAN, who holds a director position. On May 21, 2026, Sean Carney acquired 16,965 shares of Common Stock under the Issuer's 2026 Equity Incentive Plan, with a transaction price of $0.00. This award is represented as restricted stock. Following this transaction, the post-transaction shares owned by Mr. Carney amount to 32,209. The filing was signed by Stephen Feider, Attorney-in-Fact, on May 26, 2026.